(firstQuint)Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer.

 OUTLINE: This is a multi-center study.

 Sample Collection: - Tumor sample - Serum sample Treatment Regimen: - All registered patients must be planning treatment with lonafarnib.

 Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer@highlight

This is a tumor and serum collection study for patients with advanced breast cancer receiving treatment with lonafarnib.

